Coronavirus Boosts Biogen Biosimilars In First Quarter

As Company Comments On Recent US Tecfidera Ruling

 
• By Dean Rudge
  
DigitalMap
Biogen's biosimilar sales in Europe are tracking north of $800m this year • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business